Atlas Trials

Adebrelimab (SHR-1316)

5 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Adebrelimab (SHR-1316)

RecordFirmDate
Efficacy and Safety of Low-dose Bevacizumab Plus Adebrelimab Combined With Transarterial Chemoembolization Followed by Hepatic Arterial Infusion Chemotherapy (TACE-HAIC) as First-line Treatment for Unresectable Hepatocellular Carcinoma: A Single-arm Phase 2 Trial (NCT07543783)Third Affiliated Hospital, Sun Yat-Sen University2026-04-10
Adebrelimab + Chemotherapy as Neoadjuvant Therapy for Resectable NSCLC (NCT07035392)Zhangzhou Municipal Hospital2025-06-20
Phase 2 Trial of Adjuvant Adebrelimab Combined With Capecitabine in High-Risk Resected Cholangiocarcinoma: ACHIEVE (NCT06607276)The First Affiliated Hospital with Nanjing Medical University2024-09-20
A Phase II Trial of Perioperative Adebrelimab Combined With XELOX in Resectable Locally Advanced Gastric/Gastroesophageal Junction Cancer (GC/GEJC) (NCT06506292)Tianjin Medical University Cancer Institute and Hospital2024-07-01
Phase Ib/II Clinical Study of Adebrelimab in Combination With Decitabine, Albumin-bound Paclitaxel, and Gemcitabine for the First-line Treatment of Metastatic Pancreatic Cancer (NCT06454448)Tianjin Medical University Cancer Institute and Hospital2024-06-15

Track Adebrelimab (SHR-1316) automatically

Every clearance here is in the API, with alerts when new ones post.